Study Aligns with Significant Increases in Physician Search Activity at Healthgrades.com

Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX) announced receipt of the final results of E2112, the Phase 3 clinical trial conducted by ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and sponsored by the National Cancer Institute (NCI), that evaluated the investigational compound entinostat, Syndax's class I HDAC inhibitor, plus exemestane in patients with advanced hormone receptor positive, human epidermal growth factor receptor 2 negative (HR+, HER2-) breast cancer who have progressed on a non-steroidal aromatase inhibitor.

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR /OTCQB: PVOTF / FRA: NPAT) today announced that the journal Frontiers of Immunology ("Frontiers") released the results of the exploratory study on Treatment on a cohort of confirmed COVID-19 cases in Wuhan.

Men of color in the United States are at an increased risk of prostate cancer and other prostate conditions, and despite advances in diagnosis and treatment, disparities still remain.

The COVID-19 pandemic is an unprecedented global health crisis, impacting all aspects of life and society.

emocha has announced the launch of a new program with Seattle, WA-based Evergreen Treatment Services (ETS) to support patients with opioid use disorder who take methadone.

Clinic expanding services while most mental health offices shut down

AIS Healthcare is leveraging its industry-leading 503A compounding facilities to help address a national medication shortage while continuing to provide existing patients with medications of the highest quality and sterility.

A new clinical trial is being announced that could significantly increase the rate of recovery for COVID-19 patients with underlying health conditions and save lives!

American Diabetes Association® partners with Abbott to donate 25,000 CGM sensors to hospitals across the country

TailorMed expands ways for healthcare providers to maintain revenue and reduce patients' financial burdens during COVID-19 crisis

AliveCor, the leader in AI-based, personal ECG technology, announced it will offer a QTc measurement service on ECGs from AliveCor's KardiaMobile 6L, the world's only FDA-cleared six-lead personal ECG.

More than 50% of people with diabetes who have been diagnosed with COVID-19 are hospitalized, according to a report from the Centers for Disease Control and Prevention (CDC)

LiveCare announced that it has been selected as the preferred provider of remote patient monitoring for members of The Independent Physician Association of America (TIPAAA)

FDA gives emergency use authorization of "Y" splitter tubing to allow a single ventilator to assist up to four patients

In these days of the COVID-19 epidemic, many in the pharma industry are facing the challenge of accessing their customers and engaging in communication.

Statement by Sr. Mary Haddad, RSM, president and CEO, Catholic Health Association of the United States

Individuals Who are 60 Years or Older or Who Have Other High-Risk Factors for Adverse COVID-19 Outcomes to Receive VIP Access During First Hour of Each Day

Responding to the COVID-19 pandemic, Cigna today announced several actions to support and protect its colleagues in the United States so they can continue serving the company's more than 170 million customer relationship worldwide.

On March 5, U.S. House and Senate lawmakers introduced the VALID Act, which would give the Food and Drug Administration (FDA) new, expansive powers to regulate laboratory developed tests—tests that are already regulated by the Centers for Medicare and Medicaid Services (CMS) and are subject to stringent personnel, quality control, and proficiency testing requirements.